ConductScience.org, home

Paper36419829

TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.

Zou X and 2 others. Front Genet, 2022. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer. Papers, record 36419829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36419829

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TLR3 serves as a novel diagnostic and prognostic biomarker and is closely correlated with immune microenvironment in three types of cancer.
PubMed
Journal
Front Genet
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.73
iCite
Revised in PubMed
2022-11-25
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zou XXiong
2Guo YYi
3Mo ZZengnan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133176521M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma.Cancer Invest2021https://conductscience.org/library/papers/33176521PubMed
229092952TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.Cancer Res2017https://conductscience.org/library/papers/29092952PubMed
330861269Immune infiltration in renal cell carcinoma.Cancer Sci2019https://conductscience.org/library/papers/30861269PubMed
432093313TLR3 Expression Induces Apoptosis in Human Non-Small-Cell Lung Cancer.Int J Mol Sci2020https://conductscience.org/library/papers/32093313PubMed
515454922Toll-like receptor control of the adaptive immune responses.Nat Immunol2004https://conductscience.org/library/papers/15454922PubMed
633564310ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19.J Oncol2021https://conductscience.org/library/papers/33564310PubMed
731701128DriverDBv3: a multi-omics database for cancer driver gene research.Nucleic Acids Res2020https://conductscience.org/library/papers/31701128PubMed
835127830
Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation.
Front Mol Biosci2022https://conductscience.org/library/papers/35127830PubMed
933310018FunRich enables enrichment analysis of OMICs datasets.J Mol Biol2021https://conductscience.org/library/papers/33310018PubMed
1020930504Anticancer function of polyinosinic-polycytidylic acid.Cancer Biol Ther2010https://conductscience.org/library/papers/20930504PubMed
1134258261CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.Biomed Res Int2021https://conductscience.org/library/papers/34258261PubMed
1223851493The immune network in pancreatic cancer development and progression.Oncogene2014https://conductscience.org/library/papers/23851493PubMed
1332209603Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.J Immunother Cancer2020https://conductscience.org/library/papers/32209603PubMed
1431988496RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence.Cell Death Differ2020https://conductscience.org/library/papers/31988496PubMed
1527993630Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma.EBioMedicine2017https://conductscience.org/library/papers/27993630PubMed
1630527665Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression.Mol Cell2019https://conductscience.org/library/papers/30527665PubMed
1729170066Glioma epigenetics: From subclassification to novel treatment options.Semin Cancer Biol2018https://conductscience.org/library/papers/29170066PubMed
1828579323Type I Interferon in Chronic Virus Infection and Cancer.Trends Immunol2017https://conductscience.org/library/papers/28579323PubMed
1931881506Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.Transl Oncol2020https://conductscience.org/library/papers/31881506PubMed
2028407145GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.Nucleic Acids Res2017https://conductscience.org/library/papers/28407145PubMed

See all 64 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
41063980Mendelian randomization combined with single-cell sequencing analysis revealed prognostic genes related to myeloid cell differentiation in prostate cancer and experimental verification.Front Immunol2025https://conductscience.org/library/papers/41063980PubMed
40838069Systematic Analysis of an Immune-Related Gene Signature for Predicting Prognosis and Immune Characteristics in Primary Lower Grade Glioma.Biomed Res Int2025https://conductscience.org/library/papers/40838069PubMed
40716784CCR2 and TLR3: noninvasive macrophage-associated biomarkers of acute renal transplant rejection.Ren Fail2025https://conductscience.org/library/papers/40716784PubMed
40535567Mechanistic insights curcumin's anti-inflammatory in pancreatic cancer: experimental and computational evidence implicating IL1B interference via IL10RA upregulation and NLRP3/TLR3 downregulation.Front Cell Dev Biol2025https://conductscience.org/library/papers/40535567PubMed
39280680Identification and expression of prognostic-related genes in kidney renal clear cell carcinoma and their possible regulatory mechanisms.Transl Androl Urol2024https://conductscience.org/library/papers/39280680PubMed
38856710Epigenetic Induction of Cancer-Testis Antigens and Endogenous Retroviruses at Single-Cell Level Enhances Immune Recognition and Response in Glioma.Cancer Res Commun2024https://conductscience.org/library/papers/38856710PubMed
37504335Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers.Curr Oncol2023https://conductscience.org/library/papers/37504335PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36419829

GET https://conductscience.org/api/papers/v1/36419829/references?page=2